Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer

出版年份 2017 全文链接

标题

作者

关键词

Breast cancer, Multidrug resistance, Pegylated liposomal doxorubicin, P-glycoprotein, Genetically engineered mouse model

出版物

Volume 261, Issue -, Pages 287-296

出版商

Elsevier BV

发表日期

2017-07-09

DOI

10.1016/j.jconrel.2017.07.010

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started